Oral Genome is collaborating with Harmony Health and United Concordia Dental to pilot its salivary testing technology. Three Pennsylvania dental organizations have launched a pilot using Oral Genome’s testing technology to expand access to preventive care for underserved communities.
The Pittsburgh locations of North American Dental Group (NADG), Miracle Dental Associates, and the Westmoreland County Community College Dental Hygiene Program will integrate Oral Genome’s instant saliva test and mobile app into their practices.
Administered in-office or at home, the test delivers real-time insights into oral health risks such as cavities, gum disease, and diabetes. Results are immediately available to patients and can be shared with dental and medical providers, supporting integrated, preventive care.
“We joined this program because it directly supports our commitment to advancing preventive care and leveraging innovation in dentistry,” said Rafael Rondon, RDH, BS, VP of Clinical Ops and Hygiene Development, NADG. “By integrating Oral Genome into our practices, we can better identify risk factors, increase acceptance of periodontal and preventive therapies, and strengthen the bridge between oral and systemic health.”
The pilot will include about 400 children and adults on Medicaid and will focus on those with intellectual and developmental disabilities (IDD). Goals include improving patient engagement, increasing preventive care utilization, and expanding access to vital oral health
insights. Findings will guide strategies to scale successful approaches nationwide, demonstrating how innovative salivary testing can improve outcomes, reduce emergency visits, and lower long-term costs for families and payers.
Learn more at Oral Genome’s website or contact [email protected].
Sensi.AI has raised a $45 million Series C funding round led by Qumra Capital, according to a press release. Existing investors also took part in the round, including Zeev Ventures, Insight Partners, Entrée Capital, Flint Capital, and Jibe Ventures. The new funding seeks to close the massive care gap in aging. The company describes itself as a “care intelligence platform” that uses audio technology to help older adults age safely at home.
To learn more, click here.
Foundation Health, a health tech business developing an AI-powered infrastructure in pharmacy operations, care coordination, and direct-to-patient delivery, has closed a $20 million Series A funding round, according to a press release. Define Ventures led the round with participation from Vanderbilt University, Intermountain Ventures, and existing investors for the two-year old business. The fresh capital will be used to scale the company’s sales and operations teams, accelerate development of its comprehensive pharmacy solution suite, and meet growing demand from health systems and direct-to-consumer healthcare organizations seeking to reduce pharmacist administrative burden and improve patient experiences.
To learn more, click here.
Onos Health, an AI health tech startup focused on changing how health plans manage behavioral health, has raised $6.3 million in a Seed funding round, according to a press release. Haystack and Pathlight Ventures co-led the funding round, with participation from pre-seed investors Bertelsmann Healthcare Investments and Nebular. Onos helps health plans by analyzing payer data and helping them to make quick, accurate behavioral health clinical decisions and identify ideal care pathways across their entire population to maximize outcomes. These pathways help ensure members are on the right care journey and enable rapid detection of low-value care, according to the release.
“Since the pandemic, behavioral health has become the fastest-growing driver of cost for health plans. Managing that growth while ensuring people get timely, appropriate care is one of the biggest challenges in the industry,” said Martin Rosenzweig, former Chief Medical Officer of Optum Behavioral Health in the press release. “What excites me about Onos Health is their clinically aligned, responsible use of AI to help payers and providers truly work together to guide members toward the right support at the right time.”
To learn more, click here.
Previvor Edge has launched a comprehensive clinical program focused on personalizing cancer prevention and early detection, according to a press release. The company has raised $3.3 million in a pre-seed round led by CoFound Partners and Max Ventures, with participation from Humbition Capital, Red Swan Ventures, and Designer Fund, according to the release.
“As an oncologist, I’ve seen firsthand the devastation cancer causes for patients and families,” said Dr. William Oh, Chair of Previvor Edge’s Clinical Advisory Board and Director of Precision Medicine at Yale Cancer Center & Smilow Cancer Hospital in the release. “We have the tools today— genetic testing, advanced imaging, lifestyle interventions — that could dramatically change outcomes, but they aren’t reaching enough people. Previvor Edge is the first scalable model to integrate these options into a single platform in a clinically responsible manner. It has the potential to save countless lives by helping people take control of their cancer risk early, when it’s most treatable, or even before it starts.”
To learn more, click here.
Photo: champpixs, Getty Images
This is a paid member feature of MedCitizens. Please submit here and join!
